Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China
1. Pfizer agreed to market a Chinese cancer drug globally. 2. The deal is valued at approximately $6 billion. 3. Pfizer pays an upfront fee of $1.25 billion. 4. Drug SSGJ-707 targets several cancer types in clinical trials. 5. Pfizer shares rose slightly ahead of market opening.